Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 02 - 10    tags : Therapeutics    save search

Voyager Therapeutics to Participate in Upcoming Investor Conferences
Published: 2022-02-10 (Crawled : 16:20) - ir.voyagertherapeutics.com
VYGR | News | $7.57 -1.05% -1.06% 310K twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.58% C: -3.47%

conference therapeutics
Nurix Therapeutics Announces Participation in the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-10 (Crawled : 00:00) - biospace.com/
NRIX 6 d | $13.73 -2.83% -2.91% 520K twitter stocktwits trandingview |
Health Technology
| | O: -4.77% H: 0.0% C: 0.0%

health ces thc conference therapeutics svb leerink global
VistaGen Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Published: 2022-02-10 (Crawled : 23:00) - biospace.com/
VTGN | $4.75 -1.66% -1.68% 150K twitter stocktwits trandingview |
Health Technology
| | O: -2.47% H: 5.06% C: -2.53%

financial results therapeutics report results
AN2 Therapeutics Reports Phase 1b Data for Oral Epetraborole
Published: 2022-02-10 (Crawled : 23:00) - biospace.com/
ANTX | $2.42 2.11% 2.07% 45K twitter stocktwits trandingview |
| Email alert Add to watchlist

phase 1b therapeutics phase 1 report phase 2b
Regulus Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-10 (Crawled : 22:00) - prnewswire.com
RGLS | $2.23 -1.33% -1.35% 92K twitter stocktwits trandingview |
Health Technology
| | O: 2.2% H: 0.08% C: -3.81%

health thc conference therapeutics svb leerink global
Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-10 (Crawled : 22:00) - globenewswire.com
DBTX | $4.91 -0.81% -0.2% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 0.8% C: -5.39%

health thc conference therapeutics svb leerink global
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-10 (Crawled : 22:00) - globenewswire.com
TVTX | $5.46 -4.88% -5.13% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.58% H: 2.86% C: 1.41%

financial results therapeutics report results
Viracta Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-10 (Crawled : 21:00) - biospace.com/
VIRX | $0.8367 -1.31% -1.33% 55K twitter stocktwits trandingview |
Manufacturing
| | O: 4.05% H: 7.13% C: 4.87%

health thc conference therapeutics svb leerink global
Aldeyra Therapeutics to Participate in Fireside Chat at the SVB Leerink 2022 Global Healthcare Conference
Published: 2022-02-10 (Crawled : 20:00) - biospace.com/
ALDX | $3.93 0.51% 0.51% 570K twitter stocktwits trandingview |
Health Technology
| | O: -3.2% H: 9.03% C: 1.27%

health thc conference therapeutics
Healis Therapeutics acquires ownership of key botulinum toxin patent
Published: 2022-02-10 (Crawled : 20:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.5% H: 0.89% C: -0.31%

xin patent therapeutics
Stroke Therapeutics Market to register a growth of USD 1.54 billion at a CAGR of 5% | High-risk Factors for Stroke is a Key Driver | Technavio
Published: 2022-02-10 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 4.64% C: 1.43%
AMCR | $9.06 0.89% 0.0% 5.8M twitter stocktwits trandingview |
Process Industries
| | O: 0.09% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.92% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M twitter stocktwits trandingview |
Health Technology
| | O: 2.11% H: 3.46% C: 0.76%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: -2.42% H: 0.49% C: -2.63%

risk therapeutics stroke growth
CORRECTION --TransCode Therapeutics
Published: 2022-02-10 (Crawled : 15:00) - globenewswire.com
RNAZ | $0.452 -1.72% -1.75% 91K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 4.55% H: 0.0% C: -7.11%

therapeutics
Chemomab Therapeutics to Present at Aegis Virtual Conference
Published: 2022-02-10 (Crawled : 14:00) - biospace.com/
CMMB | $0.67 0.02% 3.4K twitter stocktwits trandingview |
Manufacturing
| | O: 4.51% H: 4.63% C: -1.68%

conference therapeutics
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
Published: 2022-02-10 (Crawled : 14:00) - globenewswire.com
VERA | $39.94 1.06% 1.05% 770K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -10.98% H: 1.07% C: -4.97%

offering ces therapeutics
TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE
Published: 2022-02-10 (Crawled : 13:30) - globenewswire.com
RNAZ | $0.452 -1.72% -1.75% 91K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 4.55% H: 0.0% C: -7.11%

ceo conference therapeutics
Finch Therapeutics Announces Additions to Senior Leadership Team
Published: 2022-02-10 (Crawled : 13:30) - biospace.com/
FNCH | $2.305 -17.35% -20.99% 120K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 5.5% H: 1.55% C: -5.22%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.92% H: 0.0% C: 0.0%

therapeutics
Amicus Therapeutics to Announce Full-Year 2021 Financial Results on February 24, 2022
Published: 2022-02-10 (Crawled : 13:30) - biospace.com/
FOLD 4 | $10.52 -1.77% -1.81% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 3.63% C: -0.97%

financial results therapeutics results
Denali Therapeutics Announces Continued Progress in DNL310 (ETV:IDS) Program for MPS II (Hunter Syndrome) Supporting Planned Initiation of Phase 2/3 Clinical Trial
Published: 2022-02-10 (Crawled : 13:30) - biospace.com/
DNLI | $15.55 -3.48% -3.6% 940K twitter stocktwits trandingview |
Health Technology
| | O: 1.08% H: 3.35% C: -2.74%

dnl310 phase 2 phase 2/3 program trial therapeutics syndros mps-ih
Outlook Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-10 (Crawled : 13:30) - globenewswire.com
OTLK | News P | $8.2 0.0% 240K twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 5.93% C: 2.22%

health thc conference therapeutics svb leerink global
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Published: 2022-02-10 (Crawled : 12:30) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 0.0% C: 0.0%

program therapeutics disease neurodegenerative
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.